NFKB1 and neoplasm: However, recent studies also support SIRT1 as a tumor suppressor which inhibits several oncogenic proteins such as NF‐κB, β‐catenin, and survivin under certain circumstances (Yeung et al., 2004; Firestein et al., 2008; Wang et al., 2008).